# Papillary Epinephrine Injection Combined With Rectal Indomethacin

> **NCT07173179** · PHASE4 · COMPLETED · sponsor: **Duzce University** · enrollment: 504 (actual)

## Conditions studied

- Post-ERCP Acute Pancreatitis

## Interventions

- **DRUG:** Papillary epinephrine injection combined with rectal indomethacin
- **DRUG:** Rectal indomethacin alone

## Key facts

- **NCT ID:** NCT07173179
- **Lead sponsor:** Duzce University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2023-02-01
- **Final completion:** 2023-04-01
- **Target enrollment:** 504 (ACTUAL)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07173179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07173179, "Papillary Epinephrine Injection Combined With Rectal Indomethacin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07173179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*